DSM-Firmenich AG
AEX:DSFIR

Watchlist Manager

DSM-Firmenich AG

AEX:DSFIR

Watchlist

Discount Rate

Price: 99.24 EUR 0.73% Market Closed

Updated: Jun 15, 2024

Have any thoughts about
DSM-Firmenich AG?

Write Note

Write Note Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Walt Disney Co NYSE:DIS	Media

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

This note will be permanently deleted.

Delete

Cancel

Ask me anything about

DSM-Firmenich AG

What unique competitive advantages
does DSM-Firmenich AG hold over its rivals?

What risks and challenges
does DSM-Firmenich AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of DSM-Firmenich AG.

What unique competitive advantages
does DSM-Firmenich AG hold over its rivals?

What risks and challenges
does DSM-Firmenich AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for DSM-Firmenich AG.

Provide P/S
for DSM-Firmenich AG.

Provide P/E
for DSM-Firmenich AG.

Provide P/OCF
for DSM-Firmenich AG.

Provide P/FCFE
for DSM-Firmenich AG.

Provide P/B
for DSM-Firmenich AG.

Provide EV/S
for DSM-Firmenich AG.

Provide EV/GP
for DSM-Firmenich AG.

Provide EV/EBITDA
for DSM-Firmenich AG.

Provide EV/EBIT
for DSM-Firmenich AG.

Provide EV/OCF
for DSM-Firmenich AG.

Provide EV/FCFF
for DSM-Firmenich AG.

Provide EV/IC
for DSM-Firmenich AG.

Show me price targets
for DSM-Firmenich AG made by professional analysts.

What are the Revenue projections
for DSM-Firmenich AG?

How accurate were the past Revenue estimates
for DSM-Firmenich AG?

What are the Net Income projections
for DSM-Firmenich AG?

How accurate were the past Net Income estimates
for DSM-Firmenich AG?

What are the EPS projections
for DSM-Firmenich AG?

How accurate were the past EPS estimates
for DSM-Firmenich AG?

What are the EBIT projections
for DSM-Firmenich AG?

How accurate were the past EBIT estimates
for DSM-Firmenich AG?

Compare the revenue forecasts
for DSM-Firmenich AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of DSM-Firmenich AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of DSM-Firmenich AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of DSM-Firmenich AG compared to its peers.

Compare the P/E ratios
of DSM-Firmenich AG against its peers.

Discuss the investment returns and shareholder value creation
comparing DSM-Firmenich AG with its peers.

Analyze the financial leverage
of DSM-Firmenich AG compared to its main competitors.

Show all profitability ratios
for DSM-Firmenich AG.

Provide ROE
for DSM-Firmenich AG.

Provide ROA
for DSM-Firmenich AG.

Provide ROIC
for DSM-Firmenich AG.

Provide ROCE
for DSM-Firmenich AG.

Provide Gross Margin
for DSM-Firmenich AG.

Provide Operating Margin
for DSM-Firmenich AG.

Provide Net Margin
for DSM-Firmenich AG.

Provide FCF Margin
for DSM-Firmenich AG.

Show all solvency ratios
for DSM-Firmenich AG.

Provide D/E Ratio
for DSM-Firmenich AG.

Provide D/A Ratio
for DSM-Firmenich AG.

Provide Interest Coverage Ratio
for DSM-Firmenich AG.

Provide Altman Z-Score Ratio
for DSM-Firmenich AG.

Provide Quick Ratio
for DSM-Firmenich AG.

Provide Current Ratio
for DSM-Firmenich AG.

Provide Cash Ratio
for DSM-Firmenich AG.

What is the historical Revenue growth
over the last 5 years for DSM-Firmenich AG?

What is the historical Net Income growth
over the last 5 years for DSM-Firmenich AG?

What is the current Free Cash Flow
of DSM-Firmenich AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for DSM-Firmenich AG.

P/S
Price to Sales

2.5

Current

Median

1.4

Industry

Higher than median

Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S

2.5

Market Cap

26.4B

Revenue

10.6B

All Countries

Forward Multiples

			Market Cap	P/S
CH	D	DSM-Firmenich AG AEX:DSFIR	26.4B EUR	2.5
JP		Shin-Etsu Chemical Co Ltd TSE:4063	12.3T JPY	5.1
US		Sherwin-Williams Co NYSE:SHW	75.3B USD	3.3
US		Ecolab Inc NYSE:ECL	68.6B USD	4.4
CH		Sika AG SIX:SIKA	41B CHF	3.6
CH		Givaudan SA SIX:GIVN	39.6B CHF	5.7
CN		Wanhua Chemical Group Co Ltd SSE:600309	271.5B CNY	1.5
IN		Asian Paints Ltd NSE:ASIANPAINT	2.8T INR	7.9
US		Dupont De Nemours Inc NYSE:DD	33.3B USD	2.8
US		PPG Industries Inc NYSE:PPG	29.9B USD	1.6
US		International Flavors & Fragrances Inc NYSE:IFF	24.1B USD	2.1

				Revenue Growth
CH	D	DSM-Firmenich AG AEX:DSFIR	Average P/S: 3.7 2.5	33%
JP		Shin-Etsu Chemical Co Ltd TSE:4063	5.1	25%
US		Sherwin-Williams Co NYSE:SHW	3.3	14%
US		Ecolab Inc NYSE:ECL	4.4	16%
CH		Sika AG SIX:SIKA	3.6	23%
CH		Givaudan SA SIX:GIVN	5.7	17%
CN		Wanhua Chemical Group Co Ltd SSE:600309	1.5	44%
IN		Asian Paints Ltd NSE:ASIANPAINT	7.9	32%
US		Dupont De Nemours Inc NYSE:DD	2.8	16%
US		PPG Industries Inc NYSE:PPG	1.6	10%
US		International Flavors & Fragrances Inc NYSE:IFF	2.1	2%

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/S

2-Years Forward

P/S

1.9

3-Years Forward

P/S

1.9

DSM-Firmenich AG
AEX:DSFIR

P/S
Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

DSM-Firmenich AG AEX:DSFIR

P/S Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

DSM-Firmenich AG
AEX:DSFIR

P/S
Price to Sales